Application of single-cell multiomics in the diagnosis and prognosis evaluation of community-acquired severe pneumonia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300071692

Enrollment

Unknown

Registered

2023-05-22

Start date

2023-05-31

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

community-acquired severe pneumonia

Interventions

Bacterial infection group:Not Applicable

Virus infection group:Not Applicable

control:Not Applicable

Better group:Not Applicable

Worse group:Not Applicable

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: 24-48h after ICU admission 2: severe community-acquired pneumonia patients

Exclusion criteria

Exclusion criteria: 1: Age<18 years old 2: Patients with severe non-community-acquired pneumonia 3: Patients with malignant tumors 4: Patients with immune disease or use of immunosuppressants 5: Patients during pregnancy

Design outcomes

Primary

Measure	Time frame
Single-cell omics analysis;Flow cytometric analysis;metabolomics;RNA-seq;	—

Countries

China

Contacts

Public ContactHua Xu

Tian jin First center hospital

wilsay@126.com+86 182 2277 3748

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026